Warrants of series TO7

Now it is possible to exercise the warrants of series TO7. For more information klick the button below. 

Issuance page – warrants of series TO7

Prolight Diagnostics, together with our subsidiary Psyros Diagnostics Ltd., develops innovative Point-of-Care (POC) systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood.


POC tests are performed outside the traditional hospital laboratory, for example in an emergency department, ambulance, healthcare centre or nursing home. POC tests are generally easier to perform than central lab tests and do not require complex training.

Prolight´s novel digital technology may be the start of a paradigm shift in POC testing

Established analogue POC technology

- currently used by all other products

  • Intensity measurement across the bulk sample
  • Analytica signal blends into to the background
  • Background noise limits signal-to-noise
  • Challenge to measure low concentration levels

New digital POC technology

- only used on the Psyros™ platform

  • Single molecule counting
  • Thresholding determines if the signal is on or off
  • No background noise
  • Enables measurement of ultra-low concentration levels

Did you know?

  • There still remains an express requirement for safe POC systems to rule-in and rule-out myocardial infarction by measuring high-sensitivity troponin in blood.
  • Our unique proprietary, single molecule counting (digital) POC system can detect extremely low levels of troponin.
  • The results pave the way to early rule-in or rule-out of myocardial infarction.
  • No other existing POC system can offer single molecule counting with such simplicity, precision, and low cost of production.
  • Our digital POC system meets every stringent requirement set by the market.
  • Only a small drop of blood is required to perform the test, even for multiplexed tests, where more than one analyte is measured simultaneously.
  • Our groundbreaking digital technology that detects and counts single molecules could see the beginning of a paradigm shift within POC testing.
About Prolight

Ground-breaking technology

The novel Psyros™ digital (single molecule counting) technology provides the opportunity to develop new ultra-sensitive POC tests in many clinical areas previously limited to specialized laboratories.

Potential future applications in large clinical areas:

  • Neurological pathologies (dementia, traumatic brain injury)
  • Immune system dysfunction (sepsis, autoimmune disease)
  • Rapid virus detection, including Covid
What is unique about Psyros™?

Subscribe